Veeda Clinical Research Limited
52W HIGH
Rs 498.75
52W LOW
Rs 449.4
1Y RETURN
+0.0%
About the Company
Veeda Clinical Research Limited is an Indian contract research organization providing clinical trial services including bioequivalence, early-phase, late-phase and pharmacovigilance. Headquartered in Ahmedabad with multiple facilities, Veeda serves global and domestic pharmaceutical companies and has conducted thousands of studies across therapeutic areas. The company emphasizes quality systems, volunteer safety, data integrity and regulatory compliance, with accreditations/inspections from multiple agencies.
Quick Facts
As of 7 Jul 2026
Quantity
Minimum investment Rs 1,00,000 (223 shares).
Settled in T+1 days. KYC verified dealers.
Get Veeda Clinical Research Limited's live price
Share a few details and our desk sends you the latest price, availability and how to invest.
Trusted by 5,000+ investors · your details are never shared.
FUNDAMENTALS
Key Indicators
A snapshot of Veeda Clinical Research Limited's valuation multiples and capital efficiency at a glance.
CURRENT SHARE PRICE
Rs 449.4
FACE VALUE / SHARE
Rs 2
BOOK VALUE / SHARE
Rs 131.38
PRICE TO EARNING (PE)
N/A
PRICE / BOOK
3.26
MARKET CAP
2.96K Cr
DEBT TO EQUITY
0.47
RETURN ON EQUITY
-7.77%
52 WEEK HIGH
Rs 498.75
52 WEEK LOW
Rs 449.4
FINANCIALS
Fundamentals & Financial Statements
Price / Share
₹428
P/B Ratio
3.26
Debt to Equity
0.47
Book Value
₹131.38
Face Value
₹2
| Particulars | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|
| Revenue | 288 | 409 | 388 | 610 |
| Cost of Material Consumed | 28 | 33 | 38 | 41 |
| Change in Inventory | 0 | 0 | 0 | 0 |
| Gross Margins | 90.28% | 91.93% | 90.21% | 93.28% |
| Employee Benefit Expenses | 87 | 109 | 126 | 221 |
| Other Expenses | 111 | 164 | 171 | 223 |
| EBITDA | 62 | 103 | 53 | 125 |
| OPM | 21.53% | 25.18% | 13.66% | 20.49% |
| Other Income | 39 | 8 | 19 | 11 |
| Finance Cost | 10 | 14 | 14 | 54 |
| Depreciation & Amortisation | 25 | 38 | 53 | 148 |
| EBIT | 37 | 65 | 0 | -23 |
| EBIT Margins | 12.85% | 15.89% | 0% | -3.77% |
| Profit Before Tax | 65 | 59 | 3.3 | -66 |
| PBT Margins | 22.57% | 14.43% | 0.85% | -10.82% |
| Tax | 15 | 17 | 3.6 | 1 |
| Profit After Tax | 50 | 42 | -0.3 | -67 |
| Net Profit Margin | 17.36% | 10.27% | -0.08% | -10.98% |
| EPS | ₹9.46 | ₹8 | ₹-0.04 | ₹-10.19 |
PROCESS
How to Buy Veeda Clinical Research Limited
Enquire
Share your requirement and preferred quantity with our desk.
Get a quote
Receive the latest indicative price, lot size and availability.
Complete KYC
Quick paperwork with a KYC-verified counterparty.
Receive shares
Shares credited to your demat, typically within T+1 days.
OWNERSHIP
Shareholding Pattern
Indicative ownership structure. Exact filed breakup confirmed at dealing.
CORPORATE CALENDAR
Events & Announcements
Typical annual calendar. Exact dates updated as the company announces them.
LEADERSHIP
Management Team
Standard governance structure. Named directors added as verified. Tap any role to see what they do and why it matters for investors.
REPORTS
Download Financial Results
Veeda Clinical Research Limited Financial Report
Fundamentals, financial statements and key ratios in one PDF
Need the official filed reports?
Get audited annual & quarterly filings (MCA / RTA) for Veeda Clinical Research Limited straight from our desk.
QUESTIONS
Frequently Asked Questions
NEWS & INSIGHTS
Latest on Veeda Clinical Research Limited & its sector
CORPORATE
Company Details
ISIN
INE01HQ01026
CIN
U73100GJ2004PLC044023
PAN
AACCC3633Q
REGISTRAR (RTA)
Link Intime India Pvt Ltd
DEPOSITORY
NSDL & CDSL
INCORPORATED
Apr 2004
OUTSTANDING SHARES
6,57,77,495
REGISTERED OFFICE
SHIVALIK PLAZA-A-, 2nd FLOOR OPP AHMEDABAD MANAGEMENT ASSOCIATION AMB, AHMEDABAD, Gujarat 380015, India
SECTOR
Health Care
INDUSTRY
Clinical Research Organization (CRO)
READY TO INVEST?
Enquire with Neoma Capital
Talk to a CA advisor about Veeda Clinical Research Limited. Get pricing, availability, and transfer process guidance.
Disclaimer: Prices shown are indicative and for reference purposes only. Unlisted shares carry higher risk than listed equities. Past performance is not indicative of future results. Financial statements, where shown, are compiled from company filings (MCA / RTA) and may be restated in subsequent filings. Neoma Capital does not provide investment advice. Please consult a qualified financial advisor. Transactions subject to KYC verification and SEBI regulations.